Obesity due to Melanocortin 4 Receptor (MC4R) Deficiency Is Associated with Increased Linear Growth and Final Height, Fasting Hyperinsulinemia, and Incompletely Suppressed Growth Hormone Secretion
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
CONTEXT: Melanocortin receptor 4 (MC4R) deficiency is characterized by increased linear growth greater than expected for the degree of obesity. OBJECTIVE: The objective of the investigation was to study the somatotroph axis in obese MC4R-deficient patients and equally obese controls. PATIENTS AND METHODS: We obtained anthropometric measurements and insulin concentrations in 153 MC4R-deficient subjects and 1392 controls matched for age and severity of obesity. We measured fasting IGF-I, IGF-II, IGF binding protein (IGFBP)-1, IGFBP-3, and acid-labile subunit levels in a subset of 33 MC4R-deficient patients and 36 control subjects. We examined pulsatile GH secretion in six adult MC4R-deficient subjects and six obese controls. RESULTS: Height sd score was significantly greater in MC4R-deficient children under 5 yr of age compared with controls (mean ± SEM: 2.3 ± 0.06 vs. 1.8 ± 0.04, P < 0.001), an effect that persisted throughout childhood. Final height (cm) was greater in MC4R-deficient men (mean ± SEM 173 ± 2.5 vs. 168 ± 2.1, P < 0.001) and women (mean 165 ± 2.1 vs. 158 ± 1.9, P < 0.001). Fasting IGF-I, IGF-II, acid-labile subunit, and IGFBP-3 concentrations were similar in the two groups. GH levels were markedly suppressed in obese controls, but pulsatile GH secretion was retained in MC4R deficiency. The mean maximal GH secretion rate per burst (P < 0.05) and mass per burst (P < 0.05) were increased in MC4R deficiency, consistent with increased pulsatile and total GH secretion. Fasting insulin levels were markedly elevated in MC4R-deficient children. CONCLUSIONS: In MC4R deficiency, increased linear growth in childhood leads to increased adult final height, greater than predicted by obesity alone. GH pulsatility is maintained in MC4R deficiency, a finding consistent with animal studies, suggesting a role for MC4R in controlling hypothalamic somatostatinergic tone. Fasting insulin levels are significantly higher in children carrying MC4R mutations. Both of these factors may contribute to the accelerated growth phenotype characteristic of MC4R deficiency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MC4R deficiency, which represents the most common genetic form of obesity, is characterized by hyperphagia (increased drive to eat), weight gain that begins in the first 5 years of life, disproportionate hyperinsulinemia and accelerated linear growth in childhood7,12,13.”
From Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency (2025) · cites this paper as [12]
Citations
Cites
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030
Ghrelin enhances appetite and increases food intake in humans
Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., Dhillo, W. S., Ghatei, M. A., & Bloom, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8111 · Cited by 2,494
Body mass index reference curves for the UK, 1990.
Cole, T. J., Freeman, J. V., & Preece, M. A. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.73.1.25 · Cited by 2,047
Circulating Ghrelin Levels Are Decreased in Human Obesity
Tschöp, M., Weyer, C., Tataranni, P. A., Devanarayan, V., Ravussin, E., & Heiman, M. L. (2001) · Diabetes · doi:10.2337/diabetes.50.4.707 · Cited by 2,008
Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene
Farooqi, I. S., Keogh, J. M., Yeo, G. S. H., Lank, E. J., Cheetham, T., & O'Rahilly, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022050 · Cited by 1,778
Self-citationThe Novel Hypothalamic Peptide Ghrelin Stimulates Food Intake and Growth Hormone Secretion
Wren, A. M., Small, C. J., Ward, H. L., Murphy, K. G., Dakin, C. L., Taheri, S., Kennedy, A. R., Roberts, G. H., Morgan, D. G. A., Ghatei, M. A., et al. (2000) · Endocrinology · doi:10.1210/endo.141.11.7873 · Cited by 1,593
Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15693 · Cited by 1,320
Self-citationThe Somatomedin Hypothesis: 2001
Le Roith, D., Bondy, C., Yakar, S., Liu, J.-L., & Butler, A. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.1.0419 · Cited by 1,257
Mountjoy, K. G. (1994) · Molecular Endocrinology · doi:10.1210/me.8.10.1298 · Cited by 1,156
Cited by
Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2015) · Circulation Research · doi:10.1161/circresaha.116.305697 · Cited by 1,360
Heymsfield, S. B., Peterson, C. M., Thomas, D. M., Heo, M., & Schuna, J. M. (2016) · Obesity Reviews · doi:10.1111/obr.12358 · Cited by 470
“Biological theories to explain this observation include accelerated growth in obese children with premature ossification of epiphyses leading to short adult stature (49); and MC4R-mediated influences on hypothalamic somatostatinergic tone leading to obesity and accelerated growth in children and obesity with tall adul…”
BackgroundA 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders
Zufferey, F., Sherr, E. H., Beckmann, N. D., Hanson, E., Maillard, A. M., Hippolyte, L., Macé, A., Ferrari, C., Kutalik, Z., Andrieux, J., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101203 · Cited by 326
20 YEARS OF LEPTIN: Human disorders of leptin action
Farooqi, I. S., & O'Rahilly, S. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0480 · Cited by 280
Self-citationGenetic approaches to understanding human obesity
Ramachandrappa, S., & Farooqi, I. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46044 · Cited by 194
Self-citationRare variants in single-minded 1 (SIM1) are associated with severe obesity
Ramachandrappa, S., Raimondo, A., Cali, A. M. G., Keogh, J. M., Henning, E., Saeed, S., Thompson, A., Garg, S., Bochukova, E. G., Brage, S., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68016 · Cited by 172
“SIM1 patients share many features of melanocortin-deficient patients, but notably do not share the accelerated linear growth and increased final height seen in MC4R deficiency (23).”
Self-citationMelanocortin-4 Receptor in Energy Homeostasis and Obesity Pathogenesis
(2013) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-386933-3.00005-4 · Cited by 160
Neuroendocrine Regulation of Growth Hormone Secretion
Steyn, F. J., Tolle, V., Chen, C., & Epelbaum, J. (2016) · Comprehensive physiology · doi:10.1002/cphy.c150002 · Cited by 194
Loss-of-function mutations in the melanocortin 4 receptor in a UK birth cohort
Wade, K. H., Lam, B. Y. H., Melvin, A., Pan, W., Corbin, L. J., Hughes, D. A., Rainbow, K., Chen, J.-H., Duckett, K., Liu, X., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01349-y · Cited by 133
“MC4R deficiency has also been reported to be associated with an increase in linear growth velocity attributable to hyperinsulinemia and the absence of the suppression of growth hormone levels that is usually seen in other forms of obesity 32 .”
Self-citationA comprehensive diagnostic approach to detect underlying causes of obesity in adults
van der Valk, E. S., van den Akker, E. L. T., Savas, M., Kleinendorst, L., Visser, J. A., Van Haelst, M. M., Sharma, A. M., & van Rossum, E. F. C. (2019) · Obesity Reviews · doi:10.1111/obr.12836 · Cited by 129
Neural melanocortin receptors in obesity and related metabolic disorders
Girardet, C., & Butler, A. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.004 · Cited by 128
PCSK1 Variants and Human Obesity
Ramos‐Molina, B., Martin, M., & Lindberg, I. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.12.001 · Cited by 139
Multifactorial Influences of Childhood Obesity
Ang, Y. N., Wee, B. S., Poh, B. K., & Ismail, M. N. (2012) · Current Obesity Reports · doi:10.1007/s13679-012-0042-7 · Cited by 153
“Deficiency of MC4R was found to associate with obesity by accelerated linear growth and increased final height as well as excess in insulin and partially suppress growth hormone [11].”
BackgroundSaeed, S., Bonnefond, A., Manzoor, J., Shabir, F., Ayesha, H., Philippe, J., Durand, E., Crouch, H., Sand, O., Ali, M., et al. (2015) · Obesity · doi:10.1002/oby.21142 · Cited by 115
“(POMC) (20), prohormone convertase 1 (PCSK1) (21,22), or melanocortin 4 receptor (MC4R) genes (23,24).”
BackgroundZhang, C., Forlano, P. M., & Cone, R. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.014 · Cited by 110
“In contrast, mammalian melanocortin circuits have little impact on the reproductive axis (Irani et al., 2005) and have small effects on growth that do not appear to result from measurable increases, relative to normal individuals, in growth hormone or IGF expression (Martinelli et al., 2011).”
BackgroundObesity-Associated GNAS Mutations and the Melanocortin Pathway
Mendes de Oliveira, E., Keogh, J. M., Talbot, F., Henning, E., Ahmed, R., Perdikari, A., Bounds, R., Wasiluk, N., Ayinampudi, V., Barroso, I., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2103329 · Cited by 95
Self-citationSaeed, S., Butt, T. A., Anwer, M., Arslan, M., & Froguel, P. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.03.001 · Cited by 100
Manco, M., & Dallapiccola, B. (2012) · PEDIATRICS · doi:10.1542/peds.2011-2717 · Cited by 101
Molecular Genetic Aspects of Weight Regulation
Hebebrand, J., Hinney, A., Knoll, N., Volckmar, A., & Scherag, A. (2013) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2013.0338 · Cited by 106
Chami, N., Preuss, M., Walker, R. W., Moscati, A., & Loos, R. J. F. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003196 · Cited by 84
“Besides increased fat mass, they also have more lean mass, greater bone-mineral density, and are taller compared with non-MC4R deficient individuals with obesity [8].”
BackgroundCorella, D., Ortega‐Azorín, C., Sorlí, J. V., Covas, M., Carrasco, P., Salas‐Salvadó, J., Martínez‐González, M. Á., Arós, F., Lapetra, J., Serra‐Majem, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052344 · Cited by 93
“While several studies have reported statistically significant associations between the MC4R rs17782313 and BMI or obesity [2,24,25,51], there are also studies that did not find a significant association [9,52] or found stronger associations with weight than BMI [11] and even studies that have reported an association w…”
Brouwers, B., de Oliveira, E. M., Martí-Solano, M., Filippin-Monteiro, F. B., Laurin, S., Keogh, J. M., Henning, E., Bounds, R., Daly, C. A., Houston, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108862 · Cited by 88
Self-citationHe, Q., Xiao, L., Xue, G., Wong, S. W. H., Ames, S. L., Schembre, S. M., & Bechara, A. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-92 · Cited by 85
“obesity and dietary intake [4-9].”
The Neuroendocrine Circuitry Controlled by POMC, MSH, and AGRP
Biebermann, H., Kühnen, P., Kleinau, G., & Krude, H. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-24716-3_3 · Cited by 70
Role of leptin and central nervous system melanocortins in obesity hypertension
da Silva, A. A., Carmo, J. M. D., & Hall, J. E. (2013) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e32835d0c05 · Cited by 63
“Mice with MC4R deficiency are hyperphagic and obese, and exhibit most characteristics of metabolic syndrome that are also observed in leptin deficiency such as visceral adiposity, hyperinsulinemia and insulin resistance, but these mice are not hypertensive despite marked hyperleptinemia [25]; deletion of leptin recept…”
BackgroundThearle, M. S., Muller, Y. L., Hanson, R. L., Mullins, M., AbdusSamad, M., Tran, J., Knowler, W. C., Bogardus, C., Krakoff, J., & Baier, L. J. (2012) · Diabetes · doi:10.2337/db11-0708 · Cited by 62
“The effect on linear growth may be related to the severity of MC4R deficiency, which would explain why our study, with partial loss-of-function mutations, found a relatively small effect and another recent study demonstrated a larger effect on final adult height of 5–7 cm in individuals heterozygous for complete loss-…”
BackgroundResultPrevalence and phenotypic characterization of MC4R variants in a large pediatric cohort
Vollbach, H., Brandt, S., Lahr, G., Denzer, C., von Schnurbein, J., Debatin, K., & Wabitsch, M. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.161 · Cited by 66
Lorcaserin improves glycemic control via a melanocortin neurocircuit
Burke, L. K., Ogunnowo-Bada, E., Georgescu, T., Cristiano, C., de Morentin, P. B. M., Valencia Torres, L., D'Agostino, G., Riches, C., Heeley, N., Ruan, Y., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.07.004 · Cited by 61
A novel MC4R mutation associated with childhood-onset obesity: A case report
Doulla, M., McIntyre, A. D., Hegele, R. A., & Gallego, P. (2014) · Paediatrics & Child Health · doi:10.1093/pch/19.10.515 · Cited by 66
“In combination with hyperinsulinism, incomplete suppression of growth hormone secretion may contribute to the accelerated growth phenotype characteristic of MC4R deficiency (11).”
BackgroundMelanocortin 4 receptor distribution in the human hypothalamus
Siljee, J. E., Unmehopa, U. A., Kalsbeek, A., Swaab, D. F., Fliers, E., & Alkemade, A. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0750 · Cited by 60
Heterozygous rare genetic variants in non-syndromic early-onset obesity
Serra‐Juhé, C., Martos‐Moreno, G. Á., de Pieri, F. B., Flores, R., Chowen, J. A., Jurado, L. A. P., & Argente, J. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0357-5 · Cited by 69
Associations of Obesity with Linear Growth and Puberty
Shalitin, S., & Gat‐Yablonski, G. (2021) · Hormone Research in Paediatrics · doi:10.1159/000516171 · Cited by 84
The Role of the Melanocortin System in Metabolic Disease: New Developments and Advances
Hill, J. W., & Faulkner, L. D. (2016) · Neuroendocrinology · doi:10.1159/000450649 · Cited by 63
Genetic, molecular and physiological insights into human obesity
Farooqi, I. S. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02468.x · Cited by 69
Self-citationPathophysiology of melanocortin receptors and their accessory proteins
Novoselova, T. V., Chan, L. F., & Clark, A. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.02.002 · Cited by 62
Alkemade, A., Yi, C.-X., Pei, L., Harakalova, M., Swaab, D. F., la Fleur, S. E., Fliers, E., & Kalsbeek, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3259 · Cited by 54
Löhr, H., Heß, S., Pereira, M. M. A., Reinoß, P., Leibold, S., Schenkel, C., Wunderlich, C. M., Kloppenburg, P., Brüning, J. C., & Hammerschmidt, M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.018 · Cited by 58
“In addition to obesity, loss-of-function mutations in Pomc or Mc4r also result in moderately enhanced linear growth both in rodents (Huszar et al., 1997; Yaswen et al., 1999) and humans (Farooqi et al., 2000; Krude et al., 2003; Martinelli et al., 2011).”
BackgroundBoswell, T., & Dunn, I. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00075 · Cited by 64
“The mechanisms underlying this effect are not fully understood but appear to be independent of growth hormone secretion and involve hyperinsulinemia (68, 69).”
BackgroundThe Genetic Basis of Obesity and Related Metabolic Diseases in Humans and Companion Animals
Wallis, N. J., & Raffan, E. (2020) · Genes · doi:10.3390/genes11111378 · Cited by 70
“Humans with MC4R mutations are also modestly taller than unaffected individuals of the same age and sex, or similarly obese unrelated subjects without MC4R mutations [53,131].”
BackgroundThe Brain Melanocortin System, Sympathetic Control, and Obesity Hypertension
da Silva, A. A., do Carmo, J. M., Wang, Z., & Hall, J. E. (2014) · Physiology · doi:10.1152/physiol.00061.2013 · Cited by 47
“The importance of MC4R to obesity hypertension is also supported by observations in humans with MC4R deficiency who, despite being markedly obese, exhibit lower BP, reduced 24-h norepinephrine excretion, and reduced prevalence of hypertension compared with obese subjects with normal MC4R function (17, 31).”
BackgroundLeibold, S., & Hammerschmidt, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120776 · Cited by 46
Blackett, P. R., & Sanghera, D. K. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.04.079 · Cited by 51
“The increased linear growth has been associated with incomplete growth hormone suppression consistent with possible interference with somatostatin suppression of growth hormone pulsatility.(22) Several functional polymorphisms in the gene have been detected and some have protected against obesity, but larger-scale GWA…”
BackgroundLoid, P., Mustila, T., Mäkitie, R. E., Viljakainen, H., Kämpe, A., Tossavainen, P., Lipsanen-Nyman, M., Pekkinen, M., & Mäkitie, O. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00081 · Cited by 43
“Patients with loss-of-functionMC4Rmutations typically present with severe childhood obesity, hyperphagia, hyperinsulinemia, and increased linear growth (11, 15).”
BackgroundMelanocortin‐4 receptor complexity in energy homeostasis,obesity and drug development strategies
Fatima, M. T., Ahmed, I., Fakhro, K. A., & Akil, A. A. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14618 · Cited by 57
“Homozygous variants are reported less frequently but result in more severe manifestations of obesity.(31,32) In recent studies, MC4R signalling has been implicated as a viable target for antiobesity treatment.”
BackgroundBrain Control of Insulin and Glucagon Secretion
Osundiji, M. A., & Evans, M. L. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.11.006 · Cited by 42
Gregorič, N., Grošelj, U., Bratina, N., Debeljak, M., Tanšek, M. Ž., Omladič, J. Š., Kovač, J., Battelino, T., Kotnik, P., & Stefanija, M. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.689387 · Cited by 48
“Yet, in humans, MC4R deficiency is associated with increased height gain as compared to similarly obese control population, comparable and normal IGF-1 and IGF-2 values, and increased GH secretion (35).”
BackgroundGuillot, R., Cortés, R., Navarro, S., Mischitelli, M., García-Herranz, V., Sánchez, E., Cal, L., Navarro, J. C., Míguez, J. M., Afanasyev, S., et al. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2016.04.011 · Cited by 44
“, 1997) but also in humans (Martinelli et al., 2011).”
Pan, Q., Delahanty, L. M., Jablonski, K. A., Knowler, W. C., Kahn, S. E., Florez, J. C., & Franks, P. W. (2013) · Obesity · doi:10.1002/oby.20459 · Cited by 42
“The rs17782313 SNP, which is upstream of the MC4R locus, has for example been reliably associated with common obesity in a GWAS meta-analysis (5) and also in the DPP (17), but the MC4R region in general has been of continued interest in obesity research for many years (3,5,10,20), largely because of its established ro…”
BackgroundInfluentialTrier, C., Hollensted, M., Schnurr, T. M., Lund, M. A. V., Nielsen, T. R. H., Rui, G., Andersson, E. A., Svendstrup, M., Bille, D. S., Gjesing, A. P., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-020-00673-6 · Cited by 38
Yarizadeh, H., Mirzababaei, A., Ghodoosi, N., Pooyan, S., Djafarian, K., Clark, C. C. T., & Mirzaei, K. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.04.044 · Cited by 40
“have increased growth hormone, BMC, and bone mineral density, although a concomitant increase in lean mass has not been reported [41, 42].”
BackgroundTorres, J., Abdalla, M., Payne, A., Fernandez-Tajes, J. J., Thurner, M., Nylander, V., Gloyn, A. L., Mahajan, A., & McCarthy, M. I. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.10.009 · Cited by 39
Marques, P., & Korbonits, M. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.11.001 · Cited by 37
Monogenic human obesity syndromes
Farooqi, I. S. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-820683-6.00022-1 · Cited by 39
Self-citationFarooqi, I. S. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.01.018 · Cited by 36
Self-citationA Brain-Melanocortin-Vagus Axis Mediates Adipose Tissue Expansion Independently of Energy Intake
Holland, J., Sorrell, J. E., Yates, E., Smith, K., Arbabi, S., Arnold, M., Rivir, M., Morano, R. L., Chen, J., Zhang, X., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.089 · Cited by 30
Dezfuli, G., Gillis, R. A., Tatge, J. E., Duncan, K. R., Dretchen, K. L., Jackson, P. G., Verbalis, J. G., & Sahibzada, N. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00104 · Cited by 32
“This is noteworthy as there are reports in the literature that show that mutations in theMc4r gene are associated with accelerated linear growth, which is disproportionate to the degree of obesity present (Martinelli et al., 2011).”
BackgroundRosa, M. C. D., Chesi, A., McCormack, S. E., Zhou, J., Weaver, B., McDonald, M. C., Christensen, S., Liimatta, K., Rosenbaum, M., Hakonarson, H. H., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02657 · Cited by 30
Tan, H. Y., Steyn, F. J., Huang, L., Cowley, M. A., Veldhuis, J. D., & Chen, C. (2016) · The Journal of Physiology · doi:10.1113/jp272770 · Cited by 26
“Loss of function of the MC4R is thought to contribute to a recovery in GH release (Martinelli et al. 2011), normally suppressed as a consequence of dietary weight gain and obesity (Scacchi et al. 1999).”
BackgroundMethodInfluentialAdeva‐Andany, M. M., Domínguez-Montero, A., Adeva-Contreras, L., Fernández‐Fernández, C., Carneiro-Freire, N., & González-Lucán, M. (2023) · Current Diabetes Reviews · doi:10.2174/1573399820666230816111624 · Cited by 30
Pharmacological chaperone action in humanized mouse models of MC4R-linked obesity
René, P., Lanfray, D., Richard, D., & Bouvier, M. (2021) · JCI Insight · doi:10.1172/jci.insight.132778 · Cited by 27
“Consistent with the increased linear growth previously observed in both human with MC4R deficiency (29) and in MC4R null mouse (30), an increase in axial length was observed in male and female homozygotes and heterozygotes carrying either hWT or hR165W alleles (Figure 2, G and H).”
BackgroundGenetic testing in patients with obesity
Phan-Hug, F., Beckmann, J. S., & Jacquemont, S. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.11.010 · Cited by 28
Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency
Bhatnagar, P., Ahmad, N. N., Li, X., Coghlan, M., Kaplan, L. M., & Farooqi, I. S. (2025) · Nature Medicine · doi:10.1038/s41591-025-03913-2 · Cited by 20
“MC4R deficiency, which represents the most common genetic form of obesity, is characterized by hyperphagia (increased drive to eat), weight gain that begins in the first 5 years of life, disproportionate hyperinsulinemia and accelerated linear growth in childhood 7,12,13 .”
Self-citationRegulation of Lean Mass, Bone Mass, and Exercise Tolerance by the Central Melanocortin System
Braun, T. P., Orwoll, B., Zhu, X., Levasseur, P. R., Szumowski, M., Nguyen, M. L., Bouxsein, M., Klein, R. F., & Marks, D. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042183 · Cited by 20
“Both insulin and circulating IGF-1 levels are elevated in humans with MC4R mutations, which would be expected to exert powerful trophic effects on muscle [18].”
BackgroundZorn, S., de Groot, C. J., Brandt-Heunemann, S., von Schnurbein, J., Abawi, O., Bounds, R., Ruck, L., Guijo, B., Martos-Moreno, G. Á., Nicaise, C., et al. (2025) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(25)00065-3 · Cited by 19
Self-citationZorn, S., Bounds, R., Williamson, A., Lawler, K., Hanßen, R., Keogh, J. M., Henning, E., Smith, M., Fielding, B. A., Umpleby, A. M., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03976-1 · Cited by 28
“Previous studies have described the clinical features of MC4R deficiency as hyperphagia (increased drive to eat), weight gain in the first 5 years of life, disproportionate hyperinsulinemia and accelerated linear growth in childhood 20,33 .”
Self-citationKwon, E. J., You, Y., Park, B., Ha, E., Kim, H. S., Park, H., & Kim, Y. J. (2018) · BMC Pediatrics · doi:10.1186/s12887-018-1104-0 · Cited by 22
“MC4R deficiency has been shown to be associated with elevated insulin levels and accelerated linear growth in childhood [17].”
BackgroundInfluentialMcAllan, L., Maynard, K. R., Kardian, A., Stayton, A. S., Fox, S. L., Stephenson, E. J., Kinney, C. E., Alshibli, N. K., Gomes, C., Pierre, J. F., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00205.2018 · Cited by 22
“Upstream of BDNF, deficits in MC4R function have been associated with decreased energy expenditure (3, 34), believed to be mediated through decreased Gs signaling in the dorsomedial hypothalamus (7), whereas downstream of BDNF, models of TrkB deficiency do not have reduced energy expenditure (11, 19, 29).”
BackgroundMicroRNA-7 regulates melanocortin circuits involved in mammalian energy homeostasis
LaPierre, M. P., Lawler, K., Godbersen, S., Farooqi, I. S., & Stoffel, M. (2022) · Nature Communications · doi:10.1038/s41467-022-33367-w · Cited by 19
Self-citationObesity and diabetes: the final frontier
Rendell, M. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2168643 · Cited by 23
“Melanocortin receptor 4 deficiency [73] 18q21.”
BackgroundMC4R in Central and Peripheral Systems
Wei, R., Li, D., Jia, S., Chen, Y., & Wang, J. (2023) · Advanced Biology · doi:10.1002/adbi.202300035 · Cited by 22
Ma, Y., Cai, G., Chen, J., Yang, X., Hua, G., Han, D., Li, X., Feng, D., & Deng, X. (2024) · BMC Genomics · doi:10.1186/s12864-023-09870-9 · Cited by 22
“Research has demonstrated that a deficiency in MC4R leads to increased pulsatile secretion of growth hormone, resulting in significant increases in both human height and weight [54].”
BackgroundMedical semiology of patients with monogenic obesity: A systematic review
Renard, É., Thevenard-Berger, A., & Meyre, D. (2024) · Obesity Reviews · doi:10.1111/obr.13797 · Cited by 18
Rojo, D., McCarthy, C. I., Raingo, J., & Rubinstein, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101077 · Cited by 18
“In fact, MC4R loss-of-function mutations in the human population have been linked to increased stature [33,34], and a similar phenotype was described in MC4R null-allele mutant mice [13].”
BackgroundA novel MC4R deletion coexisting with FTO and MC1R gene variants, causes severe early onset obesity
Neocleous, V., Shammas, C., Phelan, M. M., Fanis, P., Pantelidou, M., Skordis, N., Mantzoros, C. S., Phylactou, L. A., & Toumba, M. (2016) · HORMONES · doi:10.14310/horm.2002.1686 · Cited by 18
The Māori and Pacific specific CREBRF variant and adult height
Metcalfe, L. K., Krishnan, M., Turner, N. A., Yaghootkar, H., Merry, T. L., Dewes, O., Hindmarsh, J. H., de Zoysa, J., Dalbeth, N., Stamp, L. K., et al. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0437-6 · Cited by 16
Loss of the melanocortin-4 receptor in mice causes dilated cardiomyopathy
Litt, M. J., Okoye, G. D., Lark, D. S., Çakır, I., Moore, C. S., Barber, M., Atkinson, J. B., Fessel, J. P., Moslehi, J. J., & Cone, R. D. (2017) · eLife · doi:10.7554/elife.28118 · Cited by 17
“Furthermore, patients with Mc4r heterozygosity have reduced growth hormone suppression in response to obesity when compared to patients matched with standardized BMI (Martinelli et al., 2011).”
BackgroundAdults with pathogenic MC4R mutations have increased final height and thereby increased bone mass
Iepsen, E. W., Zhang, J., Hollensted, M., Madsbad, S., Hansen, T., Holst, J. J., Jørgensen, N. R., Holm, J.-C., & Torekov, S. S. (2020) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-019-01034-8 · Cited by 15
Delhanty, P. J. D., Bouw, E., Huisman, M., Vervenne, R. M. L., Themmen, A. P. N., van der Lely, A. J., & van den Akker, E. L. T. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3691-7 · Cited by 17
“Hyperinsulinemia, together with incompletely suppressed growth hormone secretion, is thought to cause the increased longitudinal growth in these subjects [13].”
BackgroundIdentification of novel LEPR mutations in Pakistani families with morbid childhood obesity
Niazi, R. K., Gjesing, A. P., Hollensted, M., Have, C. T., Grarup, N., Pedersen, O. B., Ullah, A., Shahid, G., Ahmad, W., Gul, A., et al. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0710-x · Cited by 21
“Similarly, during the first year of life, MC4R deficiency has been linked with hyperphagia and increased fat and lean mass, increased linear height, increased bone mineral density and severe early hyperinsulinemia [22, 26], although some of these associations remain controversial [27, 28].”
BackgroundRole of ADHD symptoms as a contributing factor to obesity in patients with MC4R mutations
Porfirio, M. C., Giovinazzo, S., Cortese, S., Giana, G., Lo‐Castro, A., Mouren, M., Curatolo, P., & Purper‐Ouakil, D. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.11.004 · Cited by 16
Obesity-associated MRAP2 variants impair multiple MC4R-mediated signaling pathways
Wyatt, R. A., Jamaluddin, A., Mistry, V., Quinn, C., & Gorvin, C. M. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf005 · Cited by 12
“…in the PCSK1 gene [8], heterozygous or homozygous loss-of-function mutations in MC4R are the most common cause of severe monogenic obesity [9, 10], while heterozygous inactivating mutations in the GNAS gene encoding the stimulatory G alpha protein (G α s),by which MC4R signals,also cause…”
Zandi, M., Shirazi, M. R. J., Tamadon, A., Akhlaghi, A., Salehi, M. S., Niazi, A., & Moghadam, A. A. (2014) · PubMed Central · Cited by 12
Gokul, P. R., Apperley, L. J., Parkinson, J., Clark, K., Lund, K., Owens, M., & Senniappan, S. (2024) · Hormone Research in Paediatrics · doi:10.1159/000537921 · Cited by 15
“When paired with hyperin-sulinism, the incomplete suppression of growth hormone secretion may contribute to the distinctive accelerated growth [3, 9].”
Obesity and thinness: insights from genetics
Farooqi, I. S. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0205 · Cited by 13
“The clinical features of MC4R deficiency closelymirror those seen inmice [22] and include hyperphagia, disproportionate hyperinsulinaemia, increased lean mass and increased linear growth [20,23].”
BackgroundSelf-citationImproving the diagnosis of hyperphagia in melanocortin‐4 receptor pathway diseases
Abuzzahab, M. J., Dubern, B., Goldstone, A. P., Haqq, A. M., Heymsfield, S. B., Miller, J. L., Richards, J. R., Wabitsch, M., & Yanovski, J. A. (2025) · Obesity · doi:10.1002/oby.24287 · Cited by 10
Obesity-associated GNAS mutations and the melanocortin pathway
Mendes de Oliveira, E., Keogh, J. M., Talbot, F., Henning, E., Ahmed, R., Perdikari, A., Bounds, R., Wasiluk, N., Ayinampudi, V., Barroso, I., et al. (2022) · Yearbook of pediatric endocrinology · doi:10.1530/ey.19.15.3 · Cited by 10
Self-citationMazen, I., Gammal, M. E., Elaidy, A. A., Anwar, G. M., Ashaat, E. A., Abdel‐Ghafar, S. F., & Abdel‐Hamid, M. S. (2023) · Molecular Genetics and Genomics · doi:10.1007/s00438-023-02025-1 · Cited by 12
“On the other hand, deficiency in MC4R could associate, in addition to early onset hyperphagia, with increased bone mineral density, increased linear height, and hyperinsulinemia (Martinelli et al. 2011).”
BackgroundFarooqi, I. S., & O’Rahilly, S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8642-8_2 · Cited by 13
Self-citationPostprandial Total Ghrelin Suppression Is Modulated by Melanocortin Signaling in Humans
van der Klaauw, A. A., Keogh, J. M., Henning, E., Blackwood, A., Haqq, A. M., Purnell, J. Q., & Farooqi, I. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2553 · Cited by 10
Self-citationMetabolic and Hormonal Consequencies of the „Obesity Risk“ MC4R Variant (rs12970134) in Czech Women
Bradnová, O., Vejražková, D., Vaňková, M., Lukášová, P., Včelák, J., Stanická, S., DVOŘÁKOVÁ, K., & Bendlová, B. (2015) · Physiological Research · doi:10.33549/physiolres.933119 · Cited by 9
Liu, J., Guo, C., Wang, Y., Su, M., Huang, W., & Lai, K. P. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.950130 · Cited by 10
“Another study by Martinelli’s group suggested that MC4R deficiency is correlated to increased fasting insulin levels and accelerated growth phenotypes (42).”
BackgroundXu, H., Zhang, H., Fang, Y., Yang, H., Chen, Y., Zhang, C., & Lin, G. (2021) · Cell Regeneration · doi:10.1186/s13619-021-00081-9 · Cited by 9
“The increased final height and bone mass in individuals with pathogenic MC4R mutations suggest that MC4R may have a role in bone turnover (Lepsen et al., 2020; Martinelli et al., 2011).”
BackgroundPeripheral actions and direct central–local communications of melanocortin 4 receptor signaling
Li, L., Liang, J., Zhang, C., Liu, T., & Zhang, C. (2021) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2021.02.001 · Cited by 11
Stagi, S., Bianconi, M., Sammarco, M. A., Artuso, R., Giglio, S., & de Martino, M. (2017) · InTech eBooks · doi:10.5772/66128 · Cited by 7
“It is apparently not related to a dysfunction of the GH axis [3, 49].”
BackgroundInsulin Dynamics and Pathophysiology in Youth-Onset Type 2 Diabetes
Abu-Nejem, R., & Hannon, T. S. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae463 · Cited by 8
Relevance of polymorphisms in MC4R and BDNF in short normal stature
Herrfurth, N., Volckmar, A., Peters, T., Kleinau, G., Müller, A., Cetindag, C., Schonnop, L., Föcker, M., Dempfle, A., Wudy, S. A., et al. (2018) · BMC Pediatrics · doi:10.1186/s12887-018-1245-1 · Cited by 7
Galuppo, B., Mannam, P., Bonet, J., Pierpont, B. M., Tricò, D., Haskell‐Luevano, C., Ericson, M. D., Freeman, K. T., Philbrick, W. M., Bale, A. E., et al. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01706-0 · Cited by 9
The Interaction of Obesity and Reproductive Function in Adolescents
Elliott, V., Waldrop, S., Wiromrat, P., Carreau, A., & Cree‐Green, M. (2022) · Seminars in Reproductive Medicine · doi:10.1055/s-0042-1744495 · Cited by 8
Abdullah, S., Reginold, W., Kiss, C., Harrison, K. J., & MacKenzie, J. J. (2016) · Case Reports in Pediatrics · doi:10.1155/2016/6123150 · Cited by 6
“The phenotype common to MC4R mutation carriers is hyperphagia within the first year of life leading to severe childhood obesity, increased lean mass, increased linear growth, and extreme hyperinsulinemia [10].”
Background
Metadata
- Authors
- Martinelli, C. E., Keogh, J. M., Greenfield, J. R., Henning, E., van der Klaauw, A. A., Blackwood, A., O'Rahilly, S., Roelfsema, F., Camacho-Hübner, C., Pijl, H., & Farooqi, I. S.
- Affiliations
- Universidade de São Paulo (BR)
- University of Cambridge (GB)
- Leiden University Medical Center (NL)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-01
- Volume
- 96
- Issue
- 1
- Pages
- E181-E188
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2043832763
- Cited by
- 153
- References
- 35
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 9 · 2023: 8 · 2022: 7 · 2021: 14 · 2020: 9 · 2019: 9 · 2018: 12 · 2017: 7 · 2016: 11 · 2015: 13 · 2014: 10 · 2013: 8 · 2012: 15
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- obesity, linear growth, adult height, growth hormone secretion, pulsatile growth hormone secretion, fasting hyperinsulinemia, insulin-like growth factor I, IGF binding proteins, growth hormone axis, children and adolescents, adult height prediction, MC4R agonist
- MeSH terms
- Anthropometry, Body Height, Carrier Proteins, Female, Glycoproteins, Humans, Hyperinsulinism, Immunoassay, Insulin, Insulin-Like Growth Factor I, Insulin-Like Growth Factor II, Male, Mutation, Obesity, Severity of Illness Index, Statistics, Nonparametric, Insulin-Like Growth Factor Binding Protein 1, Insulin-Like Growth Factor Binding Protein 3, Human Growth Hormone, Receptor, Melanocortin, Type 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.